US Health Agencies Recommend Pausing Valneva's Chikungunya Vaccine For Older Adults After Adverse Events

benzinga.com/general/biotech/25/05/45356303/us-health-agencies-recommend-pausing-valnevas-chikungunya-vaccine-for-older-adults-after-adverse-

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have advised a temporary halt in administering the chikungunya vaccine Valneva SE’s (NASDAQ:VALN) Ixchiq to adults aged 60 and older as they investigate reports of serious adverse events,…

This story appeared on benzinga.com, 2025-05-12 17:56:50.
The Entire Business World on a Single Page. Free to Use →